IRVINE, Calif.--(BUSINESS WIRE)--Successful adult germ line reprogramming research conducted by PrimeCell™ Therapeutics LLC (http://www.primecelltherapeutics.com) was acknowledged by three Members of Congress during the recent Capitol Hill debate over stem cell research.
